Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: A systematic literature review

Systemic Treatment in Unresectable Metastatic Well-Differentiated Carcinoid Tumors

(2012) Jonathan R. Strosberg et al.   PANCREAS

Safety review: Dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors

(2011) William H. Ludlam et al.   ADVANCES IN THERAPY

Evaluating the Characteristics and the Management of Patients With Neuroendocrine Tumors Receiving Octreotide LAR During a 6-Year Period

(2011) Lowell Anthony et al.   PANCREAS

NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor

(2010) Aaron I. Vinik et al.   PANCREAS

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

(2009) Anja Rinke et al.   JOURNAL OF CLINICAL ONCOLOGY

Octreotide LAR in Carcinoid

(2008) James C. Yao et al.   PANCREAS